Enantiocontrolled Synthesis of 3-Pyrrolines from α-Amino Allenes
FULL PAPER
NMR (CDCl3, 400 MHz): δ ϭ 7.68 (m, 2 H), 7.30 (d, J ϭ 8.0 Hz, 3-Bromo-2-ethyl-2-methyl-1-(p-tolylsulfonyl)-2,5-dihydropyrrole
2 H), 5.73 (m,1 H), 4.39 (m, 1 H), 4.05 (ddd, J ϭ 15.9, 2.7, 1.1 Hz, (4e): This compound was prepared from allene 3e by the general
1 H), 3.91 (ddd, J ϭ 15.9, 4.8, 1.7 Hz, 1 H), 2.42 (s, 3 H), 2.24 (d
sept, J ϭ 2.4, 7.1 Hz, 1 H), 1.12 (d, J ϭ 7.1 Hz, 3 H), 0.94 (d, J ϭ
procedure in 89% yield (74.8 mg); light yellow liquid. 1H NMR
(CDCl3, 400 MHz): δ ϭ 7.75 (d, J ϭ 7.8 Hz, 2 H), 7.28 (d, J ϭ
7.1 Hz, 3 H) ppm. 13C NMR (CDCl3, 100 MHz): δ ϭ 143.8, 134.3, 7.8 Hz, 2 H), 5.88 (t, J ϭ 2.3 Hz, 1 H), 4.05 (dd, J ϭ 13.4, 2.2 Hz,
129.8 (2 C), 127.5 (2 C), 126.4, 118.4, 74.6, 56.1, 31.9, 21.5, 18.7,
16.5 ppm.
1 H), 4.00 (dd, J ϭ 13.4, 2.2 Hz, 1 H), 2.41 (s, 3 H), 2.24 (app.
sext, J ϭ 7.5 Hz, 1 H), 1.66 (app. sext, J ϭ 7.1 Hz, 1 H), 1.51 (s, 3
H), 0.73 (t, J ϭ 7.8 Hz, 3 H) ppm. 13C NMR (CDCl3, 100 MHz):
δ ϭ 143.4, 137.9, 129.7 (2 C), 127.4 (2 C), 124.5, 123.7, 76.8, 54.9,
31.0, 25.5, 21.7, 8.3 ppm.
N-Benzyloxycarbonyl-3-bromo-2-isopropyl-2,5-dihydropyrrole (4bЈ):
This compound was prepared from allene 3bЈ by the general pro-
cedure in 66% yield (86.8 mg); light yellow liquid. 1H NMR
([D6]DMSO, 100 °C, 400 MHz): δ ϭ 7.35 (m, 5 H), 6.19 (m, 1 H),
5.11 (s, 2 H), 4.49 (m, 1 H), 4.23 (ddd, J ϭ 15.7, 2.7, 1.8 Hz, 1 H),
3.92 (ddd, J ϭ 15.7, 5.1, 1.8 Hz, 1 H), 2.24 (d sept, J ϭ 2.4, 7.0 Hz,
1 H), 0.92 (dd, J ϭ 7.0, 3.5 Hz, 6 H) ppm. 13C NMR ([D6]DMSO,
100 °C, 100 MHz): δ ϭ 154.9, 137.5, 129.0, 128.6, 128.5, 128.2,
117.2, 71.9, 67.1, 55.0, 31.7, 18.7, 17.7 ppm.
(R)-2-[(Benzyloxy)methyl]-3-bromo-1-(p-tolylsulfonyl)-2,5-dihydro-
pyrrole [(R)-4f]: This compound was prepared from allene 3f
(100.6 mg, 0.2929 mmol) by the general procedure but with the use
of 2 equiv. NBS at 20 °C in 51% yield (63.6 mg, 0.1506 mmol);
colorless oil. 1H NMR (CDCl3, 400 MHz): δ ϭ 7.70 (m, 2 H),
7.36Ϫ7.25 (m, 7 H), 5.87 (dd, J ϭ 4.0, 2.1 Hz, 1 H), 4.62 (d, J ϭ
12.4 Hz, 1 H), 4.53 (d, J ϭ 12.4 Hz, 1 H), 4.45 (m, 1 H), 4.10 (dd,
J ϭ 4.0, 2.1 Hz, 2 H), 3.86 (dd, 10.7, 2.2 Hz, 1 H), 3.83 (dd, J ϭ
10.7, 2.7 Hz, 1 H), 2.42 (s, 3 H) ppm. 13C NMR (CDCl3,
100 MHz): δ143.8, 138.2, 134.6, 129.8 (2 C), 128.2 (2 C), 127.5,
127.4 (2 C), 127.3 (2 C), 126.6, 116.6, 73.5, 69.6, 69.5, 55.3, 21.5
ppm.
3-Bromo-2-pentyl-1-(p-tolylsulfonyl)-2,5-dihydropyrrole (4a): This
compound was prepared from allene 3a (106.1 mg, 0.3616 mmol)
by the general procedure in 85% yield (114.5 mg, 0.3075 mmol);
colorless oil. 1H NMR (CDCl3, 400 MHz): δ ϭ 7.75 (dm, J ϭ
8.4 Hz, 2 H), 7.31 (m, 2 H), 5.76 (app q, J ϭ 2.0 Hz, 1 H), 4.46
(m, 1 H), 4.08 (app dt, J ϭ 14.7, 2.6 Hz, 1 H), 4.02 (ddd, J ϭ 14.7,
5.2, 2.0 Hz, 1 H), 2.43 (s, 3 H), 1.94 (m, 1 H), 1.76 (m, 1 H),
1.40Ϫ1.13 (m, 6 H), 0.88 (t, J ϭ 6.9 Hz, 3 H) ppm. 13C NMR
(CDCl3, 100 MHz): δ ϭ 143.7, 134.4, 129.8 (2 C), 127.4 (2 C),
125.2, 118.9, 69.2, 55.4, 32.3, 31.6, 22.6, 22.0, 21.5, 14.0 ppm.
N-(3,4-Dibromooct-2-enyl)-p-toluenesulfonamide (5): This com-
pound was isolated as a by-product from the treatment of allene
1
3a with CuBr2. H NMR (CDCl3, 300 MHz): δ ϭ 7.75 (m, 2 H),
7.33 (m, 2 H), 6.07 (t, J ϭ 6.2 Hz, 1 H), 4.65 (br. t, J ϭ 6.1 Hz, 1
H), 4.48 (t, J ϭ 7.3 Hz, 1 H), 3.73 (t, J ϭ 6.2 Hz, 2 H), 2.44 (s, 3
H), 1.93 (m, 2 H), 1.28 (m, 6 H), 0.88 (m, 3 H) ppm. 13C NMR
(CDCl3, 75 MHz): δ ϭ 143.8, 136.6, 131.6, 129.9 (2 C), 127.6, 127.2
(2 C), 57.0, 43.8, 37.9, 30.9, 27.0, 22.3, 21.6, 13.9 ppm.
(R)-3-Bromo-2-methyl-1-(p-tolylsulfonyl)-2,5-dihydropyrrole [(R)-
4c]: This compound was prepared from allene (R)-3c (93.9 mg,
0.3957 mmol) by the general procedure in 82% yield (102.6 mg,
0.3244 mmol); colorless oil, crystallizable from pentane/ether, 95:5.
Recrystallization from hexane gave enantiomerically pure white
needles; m.p. 51Ϫ57 °C. 1H NMR (CDCl3, 300 MHz): δ ϭ 7.70
(dm, J ϭ 8.3 Hz, 2 H), 7.32 (m, 2 H), 5.73 (app q, J ϭ 2.0 Hz, 1
H), 4.36 (m, 1 H), 4.10 (ddd, J ϭ 14.5, 5.5, 2.0 Hz, 1 H), 4.01 (app
dt, J ϭ 14.5, 2.5 Hz, 1 H), 2.43 (s, 3 H), 1.51 (d, J ϭ 6.4 Hz, 3 H)
ppm. 13C NMR (CDCl3, 100 MHz): δ ϭ 143.8, 134.2, 129.9 (2 C),
127.4 (2 C), 124.3, 120.5, 65.4, 54.6, 21.5, 21.2 ppm.
Acknowledgments
Financial support from the Swedish Research Council is grate-
fully acknowledged.
[1] [1a]
[1b]
L.-I. Olsson, A. Claesson, Synthesis 1979, 743.
P. L .
Beaulieu, V. M. Morisset, D. G. Garratt, Tetrahedron Lett.
1980, 21, 129.
[2] [2a]
J. A. Marshall, X. J. Wang, J. Org. Chem. 1991, 56, 4913.
A. Hoffmann-Röder, N. Krause, Org. Lett. 2001, 2537.
[2b]
(R)-tert-Butyl 3-Bromo-2-methyl-2,5-dihydro-1-pyrrolecarboxylate
[(R)-4cЈ]: This compound was prepared from allene (R)-3cЈ
(97.1 mg, 0.5299 mmol) by the general procedure in 49% yield
(55.2 mg, 0.2106 mmol); colorless liquid. 1H NMR ([D6]DMSO,
300 MHz): δ ϭ 6.07 (dd, J ϭ 3.9, 2.1 Hz, 1 H), 4.39 (m, 1 H), 4.08
(app dt, J ϭ 15.3, 2.3 Hz, 1 H), 3.95 (ddd, J ϭ 15.3, 5.4, 2.1 Hz, 1
H),1.45 (s, 9 H), 1.33 (d, J ϭ 6.3 Hz, 3 H) ppm. 13C NMR
([D6]DMSO, 100 MHz): δ ϭ 152.2, 128.8, 127.8 (2 C), 125.2 (2 C),
119.2, 78.6, 61.8, 52.1, 27.6, 18.0 ppm.
[3]
[4]
[5]
[6]
[7]
[8]
G. B. Gill, M. S. H. Idris, Tetrahedron Lett. 1985, 26, 4811.
J. A. Marshall, M. A. Wolf, J. Org. Chem. 1996, 61, 3238.
S. Ma, S. Wu, Chem. Commun. 2001, 441.
S. Ma, H. Xie, Org. Lett. 2000, 2, 3801.
R. W. Friesen, Tetrahedron Lett. 1990, 31, 4249.
S. Ma, Z. Shi, Z. Yu, Tetrahedron 1999, 55, 12137.
[9] [9a]
K. Ishii, H. Ohno, Y. Takemoto, E. Osawa, Y. Yamaoka,
N. Fujii, T. Ibuka, J. Chem. Soc., Perkin Trans. 1 1999, 2155.
[9b] A. B. Mauger, J. Nat. Prod. 1996, 59, 1205. [9c] J. M. Phang,
Current Topics in Cellular Regulation 1985, 25, 91.
A. Claesson, C. Sahlberg, Tetrahedron 1982, 38, 363.
B. A. Murrer, J. M. Brown, P. A. Chaloner, P. N. Nicholson,
D. Parker, Synthesis 1979, 350.
E. V. Dehmlow, C. Sauerbier, Liebigs Ann. Chem. 1989, 181.
S. Clough, M. E. Raggatt, T. J. Simpson, C. L. Willis, A. Whit-
ing, S. K. Wrigley, J. Chem. Soc., Perkin Trans. 1 2000, 2475.
L. Gruber, I. Tömösközi, L. Radics, Synthesis 1975, 708.
T. Kanger, M. Liiv, T. Pehk, M. Lopp, Synthesis 1993, 91.
K. Burgess, L. D. Jennings, J. Am. Chem. Soc. 1991, 113,
6129Ϫ6139.
[10]
[11]
(S)-2-Benzyl-3-bromo-1-(p-tolylsulfonyl)-2,5-dihydropyrrole [(S)-4d]:
This compound was prepared from allene (S)-3d by the general
procedure but with the use of 2 equiv. NBS at 20 °C in 44% yield
(71 mg); white solid. 1H NMR (CDCl3, 400 MHz): δ ϭ 7.71 (d,
J ϭ 9.6 Hz, 2 H), 7.37Ϫ7.19 (m, 7 H), 5.54 (app. br. q, J ϭ 1.9, 1
H), 4.66 (m, 1 H), 3.82 (app. dt, J ϭ 14.6, 2.3 Hz, 1 H), 3.77 (ddd,
14.6, 5.2, 1.9 Hz, 1 H), 3.31 (dd, J ϭ 13.9, 4.8 Hz, 1 H), 3.12 (dd,
J ϭ 13.9, 2.3 Hz, 1 H), 2.43 (s, 3 H) ppm. 13C NMR (CDCl3,
100 MHz): δ ϭ 144.1, 135.6, 134.6, 131.1 (2 C), 130.2 (2 C), 128.1
(2 C), 127.5(2 C), 127.0, 126.9, 117.9, 70.2, 55.5, 38.6, 21.8 ppm.
[12]
[13]
[14]
[15]
[16]
Received March 30, 2004
Eur. J. Org. Chem. 2004, 3240Ϫ3243
2004 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
3243